Annual Accounts Payable
$2.21 M
-$577.00 K-20.73%
01 June 2024
Summary:
Kintara Therapeutics annual accounts payable is currently $2.21 million, with the most recent change of -$577.00 thousand (-20.73%) on 01 June 2024. During the last 3 years, it has fallen by -$12.00 thousand (-0.54%).KTRA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.21 M
+$964.00 K+77.55%
01 June 2024
Summary:
Kintara Therapeutics quarterly accounts payable is currently $2.21 million, with the most recent change of +$964.00 thousand (+77.55%) on 01 June 2024. Over the past year, it has dropped by -$791.00 thousand (-26.38%).KTRA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.7% | -26.4% |
| 3 y3 years | -0.5% | -12.1% |
| 5 y5 years | +26.5% | +95.7% |
KTRA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -32.5% | -32.5% |
Kintara Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $2.21 M(-20.7%) | $2.21 M(+77.6%) |
| Mar 2024 | - | $1.24 M(-27.8%) |
| Dec 2023 | - | $1.72 M(-42.6%) |
| Sept 2023 | - | $3.00 M(+7.7%) |
| June 2023 | $2.78 M(-14.8%) | $2.78 M(+6.7%) |
| Mar 2023 | - | $2.61 M(-3.0%) |
| Dec 2022 | - | $2.69 M(-8.6%) |
| Sept 2022 | - | $2.94 M(-10.0%) |
| June 2022 | $3.27 M(+47.3%) | $3.27 M(+17.5%) |
| Mar 2022 | - | $2.78 M(-3.9%) |
| Dec 2021 | - | $2.90 M(+15.3%) |
| Sept 2021 | - | $2.51 M(+13.1%) |
| June 2021 | $2.22 M(+10.3%) | $2.22 M(+34.9%) |
| Mar 2021 | - | $1.65 M(-16.3%) |
| Dec 2020 | - | $1.97 M(+25.5%) |
| Sept 2020 | - | $1.57 M(-22.1%) |
| June 2020 | $2.01 M(+15.3%) | $2.01 M(+85.2%) |
| Mar 2020 | - | $1.09 M(+44.6%) |
| Dec 2019 | - | $750.80 K(-33.4%) |
| Sept 2019 | - | $1.13 M(-35.4%) |
| June 2019 | $1.74 M(+18.0%) | $1.74 M(+60.9%) |
| Mar 2019 | - | $1.08 M(-2.8%) |
| Dec 2018 | - | $1.12 M(+22.6%) |
| Sept 2018 | - | $909.90 K(-38.4%) |
| June 2018 | $1.48 M(+25.0%) | $1.48 M(-21.8%) |
| Mar 2018 | - | $1.89 M(+3.4%) |
| Dec 2017 | - | $1.83 M(+27.2%) |
| Sept 2017 | - | $1.44 M(+21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | $1.18 M(+102.4%) | $1.18 M(+49.3%) |
| Mar 2017 | - | $791.80 K(+53.6%) |
| Dec 2016 | - | $515.60 K(+27.1%) |
| Sept 2016 | - | $405.80 K(-30.5%) |
| June 2016 | $584.00 K(-23.4%) | $584.00 K(-9.7%) |
| Mar 2016 | - | $646.90 K(+35.0%) |
| Dec 2015 | - | $479.10 K(+28.5%) |
| Sept 2015 | - | $372.80 K(-51.1%) |
| June 2015 | $762.30 K(+211.3%) | $762.30 K(+56.8%) |
| Mar 2015 | - | $486.20 K(+89.6%) |
| Dec 2014 | - | $256.50 K(-12.8%) |
| Sept 2014 | - | $294.00 K(-27.3%) |
| June 2014 | $244.90 K(+74.3%) | - |
| Mar 2014 | - | $404.40 K(+187.8%) |
| Dec 2013 | $140.50 K(+5520.0%) | $140.50 K(-33.3%) |
| Sept 2013 | - | $210.60 K(-51.2%) |
| June 2013 | - | $431.20 K(-25.5%) |
| Mar 2013 | - | $578.90 K(>+9900.0%) |
| Dec 2012 | - | $4100.00(+64.0%) |
| Sept 2012 | - | $2500.00(0.0%) |
| June 2012 | - | $2500.00(0.0%) |
| June 2012 | $2500.00(>+9900.0%) | - |
| Mar 2012 | - | $2500.00(0.0%) |
| Dec 2011 | - | $2500.00(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(-100.0%) |
| June 2010 | $700.00 | $700.00 |
FAQ
- What is Kintara Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Kintara Therapeutics?
- What is Kintara Therapeutics annual accounts payable year-on-year change?
- What is Kintara Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly accounts payable year-on-year change?
What is Kintara Therapeutics annual accounts payable?
The current annual accounts payable of KTRA is $2.21 M
What is the all time high annual accounts payable for Kintara Therapeutics?
Kintara Therapeutics all-time high annual accounts payable is $3.27 M
What is Kintara Therapeutics annual accounts payable year-on-year change?
Over the past year, KTRA annual accounts payable has changed by -$577.00 K (-20.73%)
What is Kintara Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KTRA is $2.21 M
What is the all time high quarterly accounts payable for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly accounts payable is $3.27 M
What is Kintara Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KTRA quarterly accounts payable has changed by -$791.00 K (-26.38%)